Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
1,060,389
-
Share change
-
-1,243,560
-
Total reported value
-
$57,710,237
-
Put/Call ratio
-
70%
-
Price per share
-
$54.39
-
Number of holders
-
43
-
Value change
-
-$79,299,408
-
Number of buys
-
11
-
Number of sells
-
19
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q1 2020
As of 31 Mar 2020,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,060,389 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, CLS Investments, LLC, Orion Portfolio Solutions, LLC, BANK OF AMERICA CORP /DE/, BNP PARIBAS ARBITRAGE, SA, CITADEL ADVISORS LLC, MORGAN STANLEY, ROYAL BANK OF CANADA, WINTRUST INVESTMENTS LLC, and UBS Group AG.
This page lists
44
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.